NCT03200405

Brief Summary

The purpose of this study is to determine the exact position of a mesh which is placed in underlay position in umbilical hernia in vitro. The investigators want to gain information if the mesh lays directly next to the abdominal wall fascia or if there´s fat tissue between mesh and fascia. Furthermore they hope to get some information about the tissue incorporation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 27, 2017

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

January 17, 2019

Status Verified

January 1, 2019

Enrollment Period

9 months

First QC Date

May 23, 2017

Last Update Submit

January 16, 2019

Conditions

Keywords

umbilical herniamesh repairMRI-visibilityunderlayNANEPDynaMeshCICATDynaMeshVisiblepreperitoneal

Outcome Measures

Primary Outcomes (1)

  • MRI visibility and visible size of the mesh 4 weeks after operation

    A MRI will be done 4 weeks after the operation and it will be registered if the mesh is visible; furthermore there will be done some measurements to specify the exact position and the visible size of the mesh

    4 weeks

Secondary Outcomes (4)

  • MRI visibility and visible size of the mesh 12 months after operation

    12 months

  • intraoperative and postoperative complications (30-day morbidity)

    4 weeks

  • relapse 12 months after operation

    12 months

  • life quality 4 weeks and 12 months after operation

    12 months

Study Arms (2)

DynaMeshVisible

EXPERIMENTAL

the umbilical hernia will be fixed with a mesh, which is incorporated with Fe3O4 particles to become visible in MRI

Device: DynaMeshVisible

DynaMeshCICAT

ACTIVE COMPARATOR

the umbilical hernia will be fixed with a Non-MRI-visible PVDF Mesh

Device: DynaMeshCICAT

Interventions

The umbilical hernias will be fixed with a mesh. In this group a MRI-visible mesh will be used.

DynaMeshVisible

The umbilical hernias will be fixed with a mesh. In this group a non-visible mesh will be used.

DynaMeshCICAT

Eligibility Criteria

Age18 Years - 76 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • umbilical hernia \> 0,4 cm; \<= 3 cm
  • BMI \> 20; \< 51

You may not qualify if:

  • emergency operation
  • previous abdominal operation
  • epigastric hernia in more than 3 cm distance of the umbilical hernia
  • ascites
  • hepatic insufficiency
  • periumbilical skin disease
  • incisional umbilical hernia
  • claustrophobia
  • contraindications concerning the MRI examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Wuerzburg

Würzburg, 97080, Germany

Location

MeSH Terms

Conditions

Hernia, Umbilical

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, VentralHernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ulrich Dietz, Prof Dr Dr

    Wuerzburg UH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 23, 2017

First Posted

June 27, 2017

Study Start

October 1, 2016

Primary Completion

July 1, 2017

Study Completion

July 1, 2018

Last Updated

January 17, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations